首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Ophthalmology

Ophthalmology杂志,由Elsevier Inc.出版,于1978年创刊,Monthly,出版语言English,ISSN:0161-6420,E-ISSN:1549-4713。

投稿咨询
Ophthalmology
Ophthalmology
Ophthalmology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
10.9
CiteScore
17.2
期刊收录
SCI、SCIE

Ophthalmology(中文译名:《眼科》),ISSN:0161-6420,EISSN:1549-4713,是Elsevier Inc.出版的国际性学术期刊,创刊于1978年,以Monthly形式稳定发行,2026年总发文量约136篇。该刊采用非OA开放访问,学科归属为医学 - 眼科学。该刊是医学、眼科学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达10.9,2025年期刊CiteScore为17.2,2025年期刊自引率约4.6%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Ophthalmology长期聚焦医学、眼科学及相关产业的技术应用前沿,平均审稿周期较快,2-4周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、眼科学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Australia、Canada、GERMANY (FED REP GER)、CHINA MAINLAND、Italy等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSITY OF LONDON、HARVARD UNIVERSITY、JOHNS HOPKINS UNIVERSITY、BASCOM PALMER EYE INSTITUTE、DUKE UNIVERSITY、MASSACHUSETTS EYE & EAR INFIRMARY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
OPHTHALMOLOGY 眼科学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OPHTHALMOLOGY SCIE Q1 2 / 98

98.5

学科:OPHTHALMOLOGY SCIE Q1 1 / 98

99.49

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OPHTHALMOLOGY SCIE Q1 2 / 99

98.5

学科:OPHTHALMOLOGY SCIE Q1 1 / 99

99.49


中国学者近期发文

1
Incidence and Associated Factors of Myopic Maculopathy Progression after Posterior Scleral Contraction in High Myopi

Author:Zhao, Jian; Zhao, Xia; Jiang, Yiqin; Gong, Qianwen; Xue, Anquan; Xu, Xu; Zhu, Shuangqian; Hu, Liang

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 4, pp. 506-514. DOI: 10.1016/j.ophtha.2025.11.002

2
Efficacy and Safety of Spleen Tyrosine Kinase and VEGFR-2 Dual-Target Kinase Inhibitor (OT202) in Dry Eye A Randomized, Vehicle-Controlled Phase 2 Tria

Author:Wang, Haiou; Jin, Xiuming; Zheng, Hongmei; Zhao, Shaozhen; Chen, Luxia; Zhang, Mingchang; Liu, Hai; Xiong, Wei; Li, Li; Wen, Feng; Chen, Wei

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 4, pp. 477-486. DOI: 10.1016/j.ophtha.2025.10.023

3
Global Gender Disparities in Access to Refractive Error Services A Systematic Review and Meta-Analysi

Author:Mavi, Sonia; Whitestone, Noelle; Chan, Ving Fai; Congdon, Nathan; Ramke, Jacqueline; Piyasena, Mapa Prabhath; Gordon, Iris; Patnaik, Jennifer L.; Cherwek, David H.; Negash, Habtamu; Li, Dongfeng; Little, Julie-Anne; Virgili, Gianni

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 2, pp. 257-277. DOI: 10.1016/j.ophtha.2025.08.031

4
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Tria

Author:Korobelnik, Jean-Francois; Lanzetta, Paolo; Leal, Sergio; Holz, Frank G.; Clark, W. Lloyd; Eichenbaum, David; Iida, Tomohiro; Sun, Xiaodong; Berliner, Alyson J.; Schulze, Andrea; Zhao, Min; Schmelter, Thomas; Schmidt-Ott, Ursula; Zhang, Xin; Morgan-Warren, Peter; Hasanbasic, Zoran; Vitti, Robert; Chu, Karen W.; Reed, Kimberly; Bhore, Rafia; Cheng, Yenchieh; Bai, Zhanying; Hirshberg, Boaz; Yancopoulos, George D.; Wong, Tien Y

Journal: OPHTHALMOLOGY. 2026; Vol. 133, Issue 1, pp. 39-50. DOI: 10.1016/j.ophtha.2025.08.022

5
Re: Chou et al.: Association between semaglutide and nonarteritic anterior ischemic optic neuropathy: a multinational population-based study (Ophthalmology. 2025:132:381-388

Author:Zhu, Haiying; Zhao, Kun

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e96-e96. DOI:

6
Factual Evidence on Digital Therapeutics in Pediatric Amblyopia Insights into Rapid Axial Elongation Ris

Author:Yao, Ying; He, Yunsi; Wen, Yun; Feng, Lei; Ye, Qingqing; Xu, Zixuan; Zhou, Yusong; Pang, Yangfei; Yu, Wentong; Zhong, Yudan; Li, Qiuying; Yuan, Junpeng; Liu, Jing; Li, Jinrong

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 661-670. DOI: 10.1016/j.ophtha.2025.01.005

7
Re: Cheng et al.: Conbercept versus laser for the treatment of infants with zone II retinopathy of prematurity (Ophthalmology. 2024;131:636-638

Author:Ma, Gang; Sun, Xuequan; Liu, Guangsen

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e97-e98. DOI: 10.1016/j.ophtha.2025.03.004

8
Longitudinal Changes of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer in Highly Myopic Glaucoma A 3-Year Cohort Stud

Author:Jiang, Jingwen; Kong, Kangjie; Lin, Fengbin; Zhou, Fengqi; Song, Yunhe; Liu, Xiaoyi; Fang, Zige; Xiaokaiti, Dilimulati; Jin, Ling; Chen, Meiling; Jonas, Jost B.; Lam, Dennis S. C.; Zangwill, Linda M.; Sun, Xiaodong; Weinreb, Robert N.; Li, Fei; Zhang, Xiulan

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 644-653. DOI: 10.1016/j.ophtha.2025.01.014

9
Behavioral Intervention with Eye-Use Monitoring to Delay Myopia Onset and Progression in Children A Cluster Randomized Tria

Author:Hu, Yuanyuan; Yu, Mingkun; Han, Xiaotong; Congdon, Nathan; Wu, Ziyun; Liu, Jianping; Liu, Zhaolan; Huo, Huanhuan; Song, Jike; He, Mingguang; Bi, Hongsheng

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. 701-712. DOI: 10.1016/j.ophtha.2025.01.003

10
Re: Cheng et al.: Conbercept versus laser for the treatment of infants with zone II retinopathy of prematurity (Ophthalmology. 2024;131:636-638) REPL

Author:Cheng, Yong; Liu, Kailin; Liang, Jianhong

Journal: OPHTHALMOLOGY. 2025; Vol. 132, Issue 6, pp. e98-e99. DOI:


在线咨询

Ophthalmology

国际简称:OPHTHALMOLOGY参考译名:眼科

年发文量:136 CiteScore:17.2 是否预警:否 Gold OA文章占比:22.92% 研究类文章占比:93.38%

杂志社联系方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Ophthalmology